ShareValue.ai

ShareValue scores for VTAK: Valuation 57, Quality 32, Growth 69, Health 39.

VTAK
NYSE American

Catheter Precision Inc.

$0.58(+3.57%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 18%
Valuation
57
Fair Value
Price vs Value
Quality
32
Weak
Business Strength
Growth
69
Moderate
Revenue & Earnings
Health
39
Stressed
Financial Stability
Momentum
61
Bullish
Price Trend

Company Details

About

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.

Score Analysis

AI Investment Thesis

Data as of:Jul 16, 2026
|
Last calculated:Jul 16, 2026